Purpose: Surgery is an effective treatment for drug resistant focal epilepsy. Predictors of seizure outcome have been extensively addressed in the general population but similar data on older patients are still lacking. The aim of this study is to evaluate effectiveness and safety of surgery for patients over 50 years and to investigate variables associated to seizure outcome. Methods: We performed a single center retrospective study including 50 patients over 50 years treated surgically for drug resistant focal epilepsy between 1997 and 2014. We analyzed the rate of success of seizure control, the association of several clinical variables with seizure outcome and the rate of surgeryrelated complications. We also investigated the impact of surgery on the patients' cognitive performances and mood profile. Results: At last follow-up 78% of our patients were seizure-free, similar to patients younger than 50 years operated on in the same period (p = 1). The rate of surgery-related complications was 10%, higher compared to younger patients (p < 0.0001). Pre-surgical daily seizure frequency (p = 0.0040) and the histological diagnosis of LEAT (p = 0.0233) were associated to a poorer seizure outcome. No significant differences were evidenced between pre-and postoperative neuropsychological profiles. A slight, not statistically significant improvement of the mood profile was observed postoperatively. Conclusion: Our results suggest that surgery is an effective treatment option also for older epileptic patients, although it is burdened by a higher surgical risk as compared to younger patients. The availability of predictors of outcome also for these patients may be helpful for pre-surgical counseling.
Introduction
Surgery represents a useful and effective treatment option for drug resistant focal epilepsy. Its effectiveness and safety were already demonstrated in temporal lobe epilepsy [1] . Excellent results were reported in children [2] and in young adults [3] .
Regarding older patients, their age was thought to be a relative contraindication to epilepsy surgery owing to the perception of increased surgical risks and reduced chances of a favorable prognosis on seizures [4] [5] [6] . As a matter of fact, previous studies reported an higher rate of surgical complications in elderly patients undergoing epilepsy surgery with a rate of surgical complications ranging from 6% to 25% [3, [6] [7] [8] [9] [10] . Basically, comorbidities and other risk factors are more likely to be represented with increasing age and this could result in a certain reluctance to offer and accept surgery. In fact, during counseling, this attitude represents a significant factor influencing patient's decision [11] . The availability of predictors of postoperative seizure outcome could be a useful tool in clinical practice in order to select elderly patients with the highest chances to achieve better results with minimal surgical risks. It has been reported that improvement of patient selection positively affects prognosis after epilepsy surgery [12] but this issue has not been specifically addressed for older patients [13] . The aims of the present retrospective study are to report our experience in the surgical treatment of patients over 50 years old with drug resistant focal epilepsy, to assess the effectiveness and safety of surgery for these patients and to identify possible predictors of postoperative seizure outcome by evaluating several pre-surgical, surgical and post-surgical variables.
Finally, seizures control and surgical safety are not the only parameters to estimate postoperative outcome. The overall quality of life after surgery may be highly impacted by the effects of resections on neuropsychological functions, which could add to the physiological cognitive decline with aging [14] . For these reasons, we have also investigated if significant changes in the cognitive functions occurred between pre-and postoperative testing, although this was not the main goal of the present study.
Methods
We searched our institutional database and clinical charts for patients operated on for drug resistant focal epilepsy from 1997 to 2014 fulfilling the following criteria: an age equal or over 50 years at surgery; a postoperative follow up of at least 2 years (after this period, results may be considered stable, because outcome at two years postoperatively has been reported to predict long-term seizure control [5, 15] .)
All eligible patients were included in the present cohort. Presurgical investigation and surgery were performed only after the patients had given their informed consent. The local Ethical Committee approved the present study.
A comprehensive pre-surgical work up included: clinical history, neurological examination, interictal scalp EEG and, when needed, intensive video-EEG (VEEG) monitoring with at least one ictal recording. All patients were imaged by brain magnetic resonance imaging (MRI, 1.5-T magnet Philips ACS-NT & Achieva) using appropriate sequences, including T1-and T2-weighted images with fluid-attenuated inversion recovery (FLAIR) sequences in several planes, and a volumetric T1-weighted sequence; additional T1-wighted sequences after i.v. injection of contrast medium were obtained if required for diagnostic purposes. Only one patient did not undergo MRI for claustrophobia, but his temporal lesion was adequately visible at the brain computer tomography (CT) scan. In selected cases, fluorine-18 fluorodeoxyglucose positron emission tomography/CT scan was obtained. When appropriate, invasive monitoring with stereotactically implanted multilead intracerebral electrodes (stereo-electroencephalo-graphy, SEEG) was performed [16] . Once patient's anatomo-electro-clinical data were reviewed, a tailored microsurgical resection (and/or disconnection) was performed, with the aim to remove the epileptogenic zone (EZ) and to preserve neurological functions. While the pre-surgical evaluation remained basically unchanged during time, surgical lobar/multilobar disconnective techniques were adopted since June 2002.
Surgical specimens were routinely processed for histological and immunohistochemical investigations. Lesions were classified according to the revised World Health Organization classification for tumors of the central nervous system [17] and to recent classifications of malformations of cortical development [18] and of focal cortical dysplasias (FCD) [19] .
We classified new postoperative neurological deficits as transient (cleared at the first visit 6 months postoperatively), and permanent (still present 6 months postoperatively). Hemianopia after surgical resection of an occipital lobe was considered as an expected deficit and classified like a subgroup of the new permanent neurological deficits.
The first follow-up visits were scheduled 6 months and one year after surgery. Subsequently, follow-up controls became yearly. A control MRI study was performed at the first follow-up visit for all patients. With the term "last follow-up" we consider the last available data from outpatient visit or direct telephone contact. Postoperative seizure outcome was assessed according to the Engel's classification [20] and assigned to two outcome groups: favorable (free from disabling seizures, corresponding to Engel's class I) and unfavorable (corresponding to Engel's classes II-IV). Statistical analysis was performed to investigate if the seizure outcome, as assessed at last available follow-up (class I vs. classes II-IV), was influenced by the following pre-surgical, surgical and post-surgical variables: sex, familiar history for epilepsy, history of secondary generalized tonic-clonic (SGTC) seizures, perinatal problems, comorbidities, preoperative neurological deficits, findings of MRI (lesional/non lesional), pre-surgical SEEG, side of surgery, site of resection (temporal/extratemporal), site of extratemporal resection (frontal lobe/posterior quadrant), histology, extent of the lesion resection at postoperative MRI (presence/ absence of residual lesion), new postoperative neurological deficits, surgery-related complications, acute postoperative seizures (APOS) and epileptiform abnormalities at postoperative EEG.
Seizure outcome and surgery-related complications of our patients older than 50 years were compared with those of patients younger than 50 years operated on in the same period in our Centre.
Cognitive evaluation was performed before surgery and it was scheduled as regularly as possible up to five years postoperatively. Several tests were used to explore different cognitive domains (language, verbal memory, visuo-spatial memory/visuo-constructive functions, visual exploration, attention/executive functions, visual perception, abstract reasoning). Beck Depression Inventory II (BDI-II) was administered to estimate mood profile. This is a selfassessment instrument consisting of several items that assess the attitude and severity of symptoms related to depression. The sum of the scores obtained in each item results in a total score ranging from 0 to 63 (a score >10 was considered pathological). The sample size available for different tests could vary according to patients' compliance and to ongoing adjustment of the evaluation batteries over time. Both preoperative and postoperative neuropsychological results were categorized as the percentage of patients whose performances fell within the categories of pathological and nonpathological (outside and, respectively, within the range of normality, normalized for age and scholarship) scores. This allowed us to simplify the presentation of neuropsychological data as already illustrated elsewhere [21] .
For bivariate analysis, Fisher's two tailed exact test and KruskalWallis Rank-Sum test were used to analyze binominal and numerical variables, respectively. Statistical significance was set at P-values <0.05. Statistical analysis was performed using R 3. 
Results
Fifty patients fulfilled the inclusion criteria. They represent 3.5% of 1419 patients who underwent surgical treatment for drug resistant epilepsy in our Centre during the examined period. There were 35 males and 15 females. The mean age at surgery was 53.8 years (range 50-62), the mean duration of epilepsy was 32.5 years (range 2-59) and the mean age at seizure onset was 21.3 years (range 1-53). Seizure frequency was daily (more than 30/month) in 10 patients, weekly (5-29/month) in 23 patients, monthly (1-4/ month) in 12 patients and sporadic (less than one/month) in 5 patients. In Table 1 other details on patients' history, clinical features, pre-surgical studies and surgical pocedures are provided. In detail, comorbidities include psychiatric (3 cases), cardiovascular (5 cases), haematological (2 cases), neoplastic (3 cases) disorders and previous brain surgery (1 case). Preoperative neurological deficits consist of intellectual disability (1 case), anomia (1 case), superior quadrantanopia (2 cases), mild right inferior facial nerve palsy (1 case) and a left hemihypoesthesia (1 case). Fifteen patients did not require video-EEG recording because the other preoperative studies were concordant and therefore sufficient to define a surgical strategy without further investigations. Extratemporal resections involved the frontal lobe in 4 cases, the parietal lobe in 2 cases and the occipital lobe in 1 case, whereas in 3 cases a multilobar resection was performed. Postoperative MRI showed a complete resection/disconnection of all lesions evidenced preoperatively in all but one case. In this patient, who presented a right mesial temporal Dysembryoplastic Neuroepithelial Tumor (DNET), small lesional residual was detected postoperatively; the patient was improved, but not completely seizure-free. In the postoperative period (Table 2) , 8 patients (16%) and 2 patients (4%) presented, respectively, a new transient and a new permanent neurological deficit. One patient presented a new expected hemianopia after an occipito-parietal resection. Five patients (10%) had a surgery-related complication, in all cases associated to a neurological deficit (transient in 4 cases, permanent in one). Furthermore, 7 patients (14%) experienced an APOS. Epileptiform abnormalities at postoperative EEG were evidenced in 13 patients (26%). Results of histopathological evaluation of surgical specimens are detailed in Table 3 . Multiple pathologies were found in 12 patients (24%), which included 4 cases with FCD IIIa, 4 patients with FCD IIIb (one associated to a ganglioglioma, one to an astrocytoma WHO grade II and 2 associated to a DNET) and 4 cases with dual pathology (a hippocampal sclerosis associated in two patients with a DNET, in one case to a cavernoma and in another case to a hamartoma).
The mean postoperative follow-up was 78.5 months (range 24-216): a total of 39 patients (78%) were in class I, 7 patients (14%) in class II, 1 patient (2%) in class III and 3 patients (6%) in class IV. Among patients in class I, 20 (40%) were in class Ia (seizure free since surgery), 1 (2%) was in class Ib (non-disabling simple partial seizures since surgery), 14 (28%) were in class Ic (some postoperative seizures but seizure-free for the last two years), and 4 (8%) were in class Id (generalized convulsions at drug withdrawal but seizure-free for the last two years).
Regarding the other 1369 patients younger than 50 years, 74.6% were in class I with a mean follow-up of 117 months. Fifty of these patients (4%) presented a surgical-related complication.
At statistical analysis (Table 4) , an unfavorable seizure outcome was significantly correlated to daily seizure frequency (p = 0.0040) and with a histological diagnosis of LEAT (p = 0.0233). Considering only LEAT cases, a strong correlation of poor seizure outcome with early age at seizure onset (median age of class I and class II-IV was 26 years and 16.5 years, respectively; p = 0.0381) and duration of epilepsy (median illness duration of class I and class II-IV was 26 years and 38.5 years, respectively; p = 0.0217) was detected.
Conversely, no relationships between age at seizure onset or epilepsy duration and seizure outcome was found when considering the whole series.
We did not find any statistical difference about the seizure outcome between the groups of older and younger patients (p = 1). The rate of surgical-related complications in, respectively, older (10%) and younger (4%) patients was significantly different (p < 0.0001). In older patients, the presence of comorbidities did not correlate to the risk to develop surgical complications (p = 0.3363).
Preoperative and final postoperative neuropsychological results (mean follow-up 34.8 months, range 6-60) are summarized in Table 5 . The percentage of patients with a pathological score at the postoperative evaluation did not significantly differ from the preoperative evaluation in all the considered domains.
A slightly improvement of BDI-II scores after surgery was found statistically in trend (p = 0.0873), without correlation with seizure outcome (p = 0.3917 for patients in class I; p = 0.1516 for patients in class II-IV).
Discussion
This retrospective study confirms that surgery may be an effective treatment option also for patients over 50 years affected by drug resistant focal epilepsy. At last available follow-up, 78% of our patients were in Engel's class I, a figure comparable with that of our younger patients. These data are similar to those of the other three largest surgical series of patients in the same age range [3, 13, 22] . As in our analysis, data reported in those studies showed that epilepsy surgery is equally effective in both young and older patients. It is likely that seizure outcome is influenced by several variables, which may be differently represented in populations of patients undergoing surgery in different age ranges. For instance, in our series, MRI-negative cases accounted for 4% and 10% in patients older and, respectively, younger than 50 years. In the same way, the rates of temporal lobe resections in older and younger patients were 80% and 50% respectively. As a matter of fact, based on these characteristic, our older patients fitted the profile of optimal candidates for epilepsy surgery. Despite this, we noted that older patients presented a higher risk to experience surgical complications if compared to younger patients and this risk is not correlated with the presence of comorbidities. In agreement with this finding, previous studies have indicated age as a risk factor for complication in epilepsy surgery patients [7, 22] . Biellvi et al. reported a significant increase of surgical risk with age in their recent paper about complications in epilepsy surgery [7] and the rate of surgical-related adverse events in their patients with an age over 50 years was similar to that of our series. Nevertheless, it has been highlighted that postoperative long-lasting clinical consequences affecting the activities of daily living are equally distributed in younger and older patients [13] . In our study, the small number of patients affected by a surgery-related complication and the heterogeneity of surgical procedures made it difficult to compare our complication rate to that of other studies. Anyway, older age does not preclude a favorable seizure outcome, as suggested also by our data. Therefore, although the higher chances to develop a surgical complication should be clearly discussed during older patients' counseling, this should not be considered a contraindication to surgery per se.
Other studies reporting data on post-surgical seizure outcome of patients over 50 years presented small-sized series particularly focused on temporal lobe epilepsies [3, 6, [8] [9] [10] [23] [24] [25] . Anyway, although these studies provide evidence that carefully selected older patients may benefit from epilepsy surgery, little attention has been devoted to predictors of seizure outcome, which may be useful to guide patients' selection and, obviously, counseling.
In the present analysis, daily seizures were found to be a significant predictor of postoperative seizure recurrence. High seizure frequency has been indicated as one of the most important factors which negatively influence the quality of life of patients and their care givers [26] . Therefore, when counseling older patients with a particularly high seizure frequency before epilepsy surgery, the possibility that surgery will not be curative should be highlighted, but the patient should be also informed that a substantial reduction of seizure frequency may be a realistic goal, worthy of being considered.
A histological diagnosis of LEAT (irrespective if solitary or associated with other pathologies) correlated to poor seizure outcome in our patients. Since surgery for LEAT-related epilepsy has usually a particularly favorable prognosis on seizures [27] , this finding is difficult to explain, but it is likely correlated to a long duration of the epileptic disorder. Notably, we have found that in LEAT cases of this cohort, results on seizures are particularly poor in patients with early seizure onset and longer duration of epilepsy. This adds further support to early epilepsy surgery in patients in whom a tumoral etiology, even if indolent, is suspected.
Unfortunately, there are no available published data on predictors of outcome focused to older patients for a comparison with our results. Nevertheless, they do not match the findings reported in major studies on results of epilepsy surgery in large series unselected for age [1, 5, 20, [28] [29] [30] [31] , and this possibly reflects the peculiarity of the specific age range investigated in our study.
Seizure outcome is not the only parameter that can measure the success of surgery. Other variables, including the cognitive performance, should also be considered, owing to their substantial impact on patients' quality of life [13] . A higher risk of cognitive impairment after temporal lobe epilepsy surgery in patients older than 50 years has been previously reported [32] . Notably, our study did not reveal a significant postoperative decline of the neuropsychological performances in any of the explored domains. This may be explained by a possible underestimation of the cognitive impact of epilepsy surgery in a population of patients in which the neuropsychological outcome was not correlated to seizure outcome, resection site and side, or antiepileptic-drugs changes occurring postoperatively. On the other side, the small size of our sample and the high number and the heterogeneity of tests administered would provide unreliable results as to the neuropsychological outcome, due to an excessive stratification of the sample. In any case, our data remain worth to be reported because they suggested that a significant postoperative cognitive decline compared to preoperative assessment should not be necessarily expected in this particular age range after epilepsy surgery.
The slight postoperative improvement of BDI-II scores is rather interesting, because this questionnaire, which estimates the mood profile, may be considered as another indirect index of quality of life. Furthermore, this trend is unrelated to seizure outcome. This finding seems to challenge previous data: hence, Barbieri et al. showed that the risk of developing postoperative depression, diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria, increased approximately of 3% per year of age [33] . Anyway, this data are referred to a population of patients unselected for age. We can suppose that older patients take the decision of having epilepsy surgery with a more responsible, aware and realistic attitude as to healing expectancy. Although a detailed analysis of the pre-and postoperative neuropsychological and psychiatric profiles was not the aim of the present study, these issues are worth to be specifically addressed in future studies on surgery for epilepsy in older patients, who are obviously more likely to present with age-related, subtle cognitive derangement which may be worsened by resective surgery. Accordingly, attention should be devoted in future studies also to psychiatric, social, employment aspects and quality of life specific of this particular age range.
Although this study presents one of the largest surgical series of epileptic patients older than 50 years, unselected for both site of surgery and etiological substrate, it has several limitations. The small sample size, the lack of a control group and the bias related to the single Centre, retrospective nature of this study limit the general relevance of our findings. Furthermore, owing to the limited sample size, a multivariate statistical analysis was not feasible, thus preventing the evaluation of possible combined effects of prognostic factors or of other confounders. Finally, a retrospective analysis is not ideal for the estimation of surgical complications, which might be underestimated. This implicitly enhances the relevance of our findings concerning the higher risk of surgical complications in this particular age range.
Conclusions
The analysis of this cohort of patients undergoing surgery with an age over than 50 years suggests that surgery is an effective treatment option for drug resistant focal epilepsy also in this age range, with 78% of patients in Engel's Class I. The neuropsychological profile and mood are not significantly affected postoperatively. The accurate preoperative selection and counseling of patients is essential, especially for those with daily frequency of seizures and presumed LEAT-related epilepsy, who may be more likely candidates to an unfavorable seizure outcome. Patients in this age range should be also aware that a significantly higher surgical risk exists compared to younger patients. Further studies in larger surgical series are needed, in order to elucidate the real beneficial impact of surgery in all epilepsy-related domains.
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